Ebola vaccines produced lasting antibodies during trial: Studies
Briefly

Studies in West Africa said that the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children and adults.Ebola vaccines developed by Johnson & Johnson and Merck & Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies conducted in West Africa.
Read at www.aljazeera.com
[
add
]
[
|
|
]